Aridis Pharmaceuticals, Inc.
ARDS
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 84.21% | -98.56% | -72.93% | 158.54% | -70.14% |
| Total Receivables | 72.33% | 200.00% | -91.94% | 400.00% | -84.39% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -0.20% | 12.82% | -5.42% | -11.33% | 99.15% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -8.44% | -20.64% | -12.26% |
| Total Current Assets | 5.82% | -40.85% | -43.52% | 34.64% | -33.13% |
|
|
|||||
| Total Current Assets | 5.82% | -40.85% | -43.52% | 34.64% | -33.13% |
| Net Property, Plant & Equipment | -9.85% | -9.76% | -9.32% | -14.33% | -8.67% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -7.14% | -6.67% | -11.76% | -5.56% | -5.26% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -8.72% | 0.11% | -5.83% | -4.85% |
| Total Assets | 0.80% | -31.29% | -35.80% | 21.25% | -27.36% |
|
|
|||||
| Total Accounts Payable | -13.26% | 51.42% | 78.47% | -45.44% | 65.56% |
| Total Accrued Expenses | -9.10% | -10.07% | -1.63% | 12.60% | 12.85% |
| Short-term Debt | -- | -- | -59.92% | -37.55% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -24.69% | 104.36% | -40.03% | -48.10% | 1,518.87% |
| Total Finance Division Other Current Liabilities | -1.99% | -97.89% | -5.36% | -1.04% | -1.64% |
| Total Other Current Liabilities | -1.99% | -97.89% | -5.36% | -1.04% | -1.64% |
| Total Current Liabilities | -14.28% | -42.44% | -3.98% | -12.72% | 34.91% |
|
|
|||||
| Total Current Liabilities | -14.28% | -42.44% | -3.98% | -12.72% | 34.91% |
| Long-Term Debt | -- | -- | -- | -- | -67.96% |
| Short-term Debt | -- | -- | -59.92% | -37.55% | -- |
| Capital Leases | -14.77% | -12.72% | -11.15% | -9.65% | -8.63% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 0.00% | 0.00% | -7.41% |
| Total Liabilities | -14.30% | -42.66% | -4.14% | -18.81% | 7.45% |
|
|
|||||
| Common Stock & APIC | 1.15% | 0.12% | 1.39% | 8.42% | 0.23% |
| Retained Earnings | -0.04% | 6.00% | -3.48% | -3.37% | -4.55% |
| Treasury Stock & Other | 19.32% | 10.39% | 17.05% | -- | -- |
| Total Common Equity | 20.87% | 46.51% | -15.06% | 32.36% | -28.25% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.87% | 46.51% | -15.06% | 32.36% | -28.25% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.87% | 46.51% | -15.06% | 32.36% | -28.25% |
|
|
|||||